A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...

Looking for some help with today's NYT Strands? An extra hint and the answers are right here to help you finish the grid and ...

Base editing, the process used to make the changes, only nicks one strand of DNA, avoiding the major DNA errors that made ...

Therapy resistance remains one of the most formidable challenges in oncology. Despite significant advances in targeted ...